Chiesi Farmaceutici S.p.A. — China drug registrations and re-registration deadlines
9 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-10-11.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220035 | Beclometasone Dipropionate，Formoterol Fumarate and Glycopyrrolate Inhalation Aerosol 倍氯福格吸入气雾剂 | 2027-04-11 | 2026-10-11 |
| 国药准字HJ20130214 | Beclometasone Dipropionate Suspension for Inhalation 吸入用丙酸倍氯米松混悬液 | 2028-02-13 | 2027-08-13 |
| 国药准字HJ20140379 | Ferriprox 去铁酮片 | 2029-05-29 | 2028-11-29 |
| 国药准字HJ20240144 | Beclometasone Dipropionate and Formoterol Fumarate Powder for Inhalation 倍氯米松福莫特罗吸入粉雾剂 | 2029-11-30 | 2029-05-30 |
| 国药准字HJ20181201 | Curosurf 猪肺磷脂注射液 | 2030-03-05 | 2029-09-05 |
| 国药准字HJ20181202 | Curosurf 猪肺磷脂注射液 | 2030-03-05 | 2029-09-05 |
| 国药准字HJ20260012 | Lomitapide Mesylate Capsules 甲磺酸洛美他派胶囊 | 2031-01-26 | 2030-07-26 |
| 国药准字HJ20260013 | Lomitapide Mesylate Capsules 甲磺酸洛美他派胶囊 | 2031-01-26 | 2030-07-26 |
| 国药准字HJ20260014 | Lomitapide Mesylate Capsules 甲磺酸洛美他派胶囊 | 2031-01-26 | 2030-07-26 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.